Neurol. praxi. 2015;16(5):290-292

Varicella, herpes zoster, complications and postherpetic neuralgia, prevention

MUDr. Lucie Růžičková Jarešová
Dermatovenerologie, Nemocnice Na Homolce, Praha
L DermaMedEst s. r. o., Praha

The varicella-zoster virus is the only virus that can cause two different diseases: chickenpox (varicella) and shingles (herpes zoster). Primary infection is characterized by a generalized vesicular eruption on an erythematous base of the skin and the mucosa. Endogenous infection is manifested by a vesicular eruption in a herpetiform pattern along the course of one or more nerve roots, the dermatomes. Primary infection is typical for childhood, causing chickenpox. It most commonly affects children aged three to six years. During the period of primary infection, the virus travels along the sensory nerve from the skin to the appropriate ganglion where it remains in a latent state. Herpes zoster occurs as a result of reactivation of latent viruses. It is an inflammatory disease of the posterior horns of the spinal cord or of brain cells with skin involvement. Postherpetic neuralgia that is often treatment resistant is the most frequent complication. The best way to prevent this complication is early diagnosis and treatment. Since April 2014, vaccine against herpes zoster has been available in the Czech Republic as the first among central and eastern European countries.

Keywords: varicella-zoster virus, varicella, herpes zoster, postherpetic neuralgia, pain, antiviral drugs, prevention

Published: October 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Růžičková Jarešová L. Varicella, herpes zoster, complications and postherpetic neuralgia, prevention. Neurol. praxi. 2015;16(5):290-292.
Download citation

References

  1. Albe-Fessard D. Bolest - mechanizmy a základy léčení, Grada, Praha 1998: 224.
  2. Ambler Z, Bednařík J, Keller O. Doporučený postup pro léčbu neuropatické bolesti, http://www.neuromuskularni-sekce.cz/index.php?pg=odborne-materialy-doporuceny-postup-pro-lecbu-neuropaticke-bolesti, III. 1, III. 2.
  3. Braun-Falco O, Plewig G, Wolff HH. Dermatológia a venerológia, Vydavatelstvo Osveta 2001: 43-45. Go to original source...
  4. Gross M. Příručka léčebné lokální anestezie, Grada, Praha 1997: 214.
  5. Havlík J. Infekční nemoci - příručka pro praktické lékaře, Galen, Praha, 1998: 221.
  6. Opavský R. Postherpetická neuralgie a její léčba, Dermatologia pre praxi, Solen, 2009: 74-75.
  7. Oxman MN, Levin MD MJ, Johnson MD GR, Schmader MS KE, Straus MD SE, Gelb MD LD. The New England Journal of Medicine: A Vaccine to Prevent Herpes Zoster and Postherpetic, Neuralgia in Older Adults, 352; 22, www.nejm.org june 2, 2005.
  8. Schmader KE, Levin JM, Gnann JW Jr, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SCH, Zhao Y, Li X, Chan ISF, Annunziato PW, Parrino J. Education and Clinical Centers, Durham, Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years, Clinical Infectious Diseases Advance Access published January 30, 2012. Go to original source... Go to PubMed...
  9. Wolff K, Johnson RA. Fitzpatricks, Color atlas and synopsi sof clinical dermatology, 2005: 821-827.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.